SCHEMBL198523

SCHEMBL198523

CCCCOC(=O)c1cccc(Cl)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 8/20 0.59
L3MBTL1 Q9Y468 2/20 0.56
CYP1A2 P05177 3/20 0.56
CYP2C19 P33261 3/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
CYP2C9 P11712 2/20 0.56
HPGD P15428 2/20 0.56
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
TSHR P16473 3/20 0.55
LMNA P02545 3/20 0.55
CYP2D6 P10635 1/20 0.55
MAPK1 P28482 1/20 0.55
NR1H2 P55055 1/20 0.55
RNASEL Q05823 1/20 0.55
TDP1 Q9NUW8 1/20 0.54
CYP3A4 P08684 1/20 0.54
PDE4D Q08499 1/20 0.54
ALDH1A1 P00352 1/20 0.54
CHRM2 P08172 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL10348735 0.98 ESR1 (0.57) ESR1L3MBTL1CYP1A2CYP2C19SMN1; SMN2
Hydrogen Peroxide SCHEMBL27761851 0.98 ESR1 (0.57) ESR1L3MBTL1CYP1A2CYP2C19SMN1; SMN2
SCHEMBL6057136 0.95 LMNA (0.56) ESR1HPGDNPC1RAB9ATSHR
SCHEMBL6057231 0.94 LMNA (0.58) ESR1NPC1RAB9ATSHRLMNA
SCHEMBL30692290 0.94 LMNA (0.58) ESR1NPC1RAB9ATSHRLMNA
SCHEMBL28807886 0.94 LMNA (0.58) ESR1NPC1RAB9ATSHRLMNA
SCHEMBL28437780 0.94 LMNA (0.58) ESR1NPC1RAB9ATSHRLMNA
SCHEMBL14335029 0.91 ESR1 (0.50) ESR1L3MBTL1CYP1A2CYP2C19SMN1; SMN2
SCHEMBL6057368 0.90 LMNA (0.64) ESR1L3MBTL1HPGDNPC1RAB9A
SCHEMBL811440 0.90 TDP1 (0.61) ESR1L3MBTL1HPGDRAB9ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102834420-B Internal and external donor compounds for olefin polymerization catalysts ii BASF CORP. (US) 2014-10-22 CN claimed
US-8569195-B2 Internal and external donor compounds for olefin polymerization catalysts II BASF CORPORATION (US) 2013-10-29 US claimed
CN-102834420-A Internal and external donor compounds for olefin polymerization catalysts ii BASF CORP 2012-12-19 CN claimed
CN-1301991-C Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same STC NARA CO LTD (KR) 2007-02-28 CN claimed
CN-1571784-A Piperidine derivatives, process for preparing the same, and pharmaceutical composition for treating alzheimer's disease containing the same STC NARA CO LTD (KR) 2005-01-26 CN claimed
WO-2017050259-A1 PRODRUGS OF GAMMA-HYDROXYBUTYRIC ACID, COMPOSITIONS AND USES THEREOF XW LABORATORIES INC. (KY) 2017-03-30 WO disclosed
EP-2782938-B1 HIGH ACTIVITY CATALYST FOR OLEFIN POLYMERIZATION BASF CORP (US) 2016-08-31 EP disclosed
US-20160128945-A1 CONTROLLED RELEASE PREPARATION TAKEDA PHARMACEUTICAL (JP) 2016-05-12 US disclosed
CN-102365255-B Method for producing alcohol compound and catalyst therefor SUMITOMO CHEMICAL CO 2015-01-07 CN disclosed
CN-102834420-B Internal and external donor compounds for olefin polymerization catalysts ii BASF CORP. (US) 2014-10-22 CN disclosed
CN-104053682-A High activity catalyst component for olefin polymerization and method of using the same BASF SE 2014-09-17 CN disclosed
CN-102365254-B Method for producing alcohol compound SUMITOMO CHEMICAL CO 2014-08-27 CN disclosed
US-20010031841-A1 Procatalysts, catalyst systems, and use in olefin polymerization WESTLAKE LONGVIEW CORPORATION 2001-10-18 US disclosed
US-20010029286-A1 Procatalysts, catalyst systems, and use in OLEFIN polymerization EASTMAN CHEMICAL COMPANY, A CORP. OF DELAWARE 2001-10-11 US disclosed
US-20010025005-A1 Procatalysts, catalyst systems, and use in olefin polymerization EASTMAN CHEMICAL COMPANY, A CORPORATION OF DELAWARE 2001-09-27 US disclosed
US-6271321-B1 CATALYTIC POLYMERIZATION OR COPOLYMERIZATION OF ETHYLENE AND OLEFIN MONOMERS EASTMAN CHEMICAL COMPANY 2001-08-07 US disclosed
WO-2000075203-A1 PROCESS FOR PRODUCING ETHYLENE/OLEFIN INTERPOLYMERS EASTMAN CHEMICAL COMPANY (US) 2000-12-14 WO disclosed
WO-2000075202-A1 PROCESS FOR PRODUCING ETHYLENE/OLEFIN INTERPOLYMERS EASTMAN CHEMICAL COMPANY (US) 2000-12-14 WO disclosed
WO-2000075204-A1 PROCESS FOR PRODUCING ETHYLENE/OLEFIN INTERPOLYMERS EASTMAN CHEMICAL COMPANY (US) 2000-12-14 WO disclosed
CN-1253152-A Alkoxy silicane binder used as accessory ingredient in spraying ink DU PONT (US) 2000-05-17 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160128945-A1 CONTROLLED RELEASE PREPARATION SLC18A1, MLN, GCG ESR1 4774/4885L3MBTL1 4751/4885CYP1A2 860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.